Connect Sign In
ARUP Consult®, a free source of expert guidance in laboratory testing, has released updated resources on testing for group A Streptococcus, Toxocara, and Echinococcus infections.
Cases of Lyme disease, Rocky Mountain spotted fever, and other tickborne illnesses are rising across the U.S. ARUP Consult’s testing resources can aid clinicians in diagnosing tickborne diseases.
Videos and podcasts produced by ARUP Laboratories about the function of COVID-19 vaccines and the challenges in navigating the pandemic have earned top prizes from the 26th annual Viddy Awards.
ARUP Consult® has released new and updated resources on Prenatal Testing for Chromosomal Abnormalities and Neural Tube Defects, Soft Tissue Sarcomas, and COVID.
Two years into the COVID-19 pandemic, when the highly contagious Omicron variant of SARS-CoV-2 has infected millions in the United States alone, most of us have some immunity against the virus.
ARUP Consult® has released updated resources on Hereditary Thrombophilia, Group B Streptococcal Disease, and Paraneoplastic Neurologic Syndromes (PNSs).
Managing the challenge of a global healthcare crisis such as the COVID-19 pandemic requires collaboration, clear and abundant communication, and planning to allow a healthcare system to adapt.
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.
Although vaccines have not brought the pandemic to its end, they have proven to be a potent tool in blocking the spread of the virus. But many wonder whether antibodies are doing their job.
ARUP Laboratories has reconstructed an additional lab dedicated solely to high-throughput COVID-19 molecular diagnostic testing to meet renewed demand for testing.
A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 neutralizing antibodies, according to an analysis recently published by experts at ARUP Laboratories.
Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status in settings such as schools or workplaces, but its role has changed as the pandemic has evolved.
